Celgene Switzerland LLC's Net Worth
-$81 Million
Who is Celgene Switzerland LLC?
Celgene Switzerland LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS, INC., Jounce Therapeutics, Inc., and Juno Therapeutics, Inc..
SEC CIK
Celgene Switzerland LLC's CIK is 0001661486
Past Insider Trading and Trends
2017 was Celgene Switzerland LLC's most active year for acquiring shares with 3 total transactions. Celgene Switzerland LLC's most active month to acquire stocks was the month of December. 2017 was Celgene Switzerland LLC's most active year for disposing of shares, totalling 1 transactions. Celgene Switzerland LLC's most active month to dispose stocks was the month of January. 2018 saw Celgene Switzerland LLC paying a total of $114,054,636.00 for 1,702,308 shares, this is the most they've acquired in one year. In 2017 Celgene Switzerland LLC cashed out on 10,448,100 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $23.785
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.33% | 403.23K |
$31.00 | $12,499,975.00 | 1.78M |
Nov 12
| |||
Form 4/A
| +162.61% | 851.15K |
$67.00 | $57,027,318.00 | 1.37M |
Jan 23
| |||
Form 4
| +162.61% | 851.15K |
$67.00 | $57,027,318.00 | 1.37M |
Jan 23
| |||
Form 4
| +50.71% | 624.58K |
$49.50 | $30,916,462.50 | 1.86M |
Apr 24
| |||
| No matching records found | |||||||||
Jounce Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.46M |
$16.00 |
—
| 3.46M |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Juno Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||